Repifermin human genome sciences/GlaxoSmithKline

IDrugs

Volumn 4, Issue 7, 2001, Pages 813-819

  Wheeler, Glen ^a  

^a NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746961100     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. 277309 Human Genome Sciences Initiates phase I studies of KGF-2, a new wound-healing therapy/Studies will test safety of second genomicsderived therapeutic product for potential use, both systemically and to treat wounds on the skin's surface. Human Genome Sciences Inc PRESS RELEASE 1998 February 10
2. 288548 Human Genome Sciences announces successful safety trial of novel cancer drug; first genomic product to enter phase II trials. Human Genome Sciences Inc PRESS RELEASE 1998 June 2
3. 295896 Human Genome Sciences advances clinical testing of KGF-2 to phase II studies. Human Genome Sciences Inc PRESS RELEASE 1998 August 25
4. 306496 Inflammation Research Association Ninth International Conference (Part II) Hershey PA, IDDB MEETING REPORT 1998 November 1-5
5. 314534 Human Genome Sciences Initiates phase II human clinical trials of KGF-2, a new wound-healing drug - third HGSI drug candidate enters efficacy studies. Human Genome Sciences Inc PRESS RELEASE 1999 February 10
6. 316474 Human Genome Sciences Inc describes three new drugs in human clinical trials and unveils functional genomics and patent programs. Human Genome Sciences Inc PRESS RELEASE 1999 February 25
7. 343362 Functional Genomics - Fourth Annual International Conference Seattle, WA, USA. Hooft R IDDB MEETING REPORT 1999 October 4-6 Presentation of preliminary data on VEGF-2, MP1F-1 and KGF-2 at the Functional Genomics Fourth Annual International Conference.
8. 352908 Human Genome Sciences announces phase II human clinical trials of Repifermin for cancer treatment related mucositis. Human Genome Sciences Inc PRESS RELEASE2000 January 19
9. 364608 Human Genome Sciences reports first quarter financial results; company's lead in genomics-based antibody and protein drug development enhanced by quarter's activities; financial strength increases. Human Genome Sciences Inc PRESS RELEASE2UQO April 27
10. Efficacy of keratinocyte growth factor-2 (KGF-2) when administered prophylactically or at the initiation of indomethacin. induced intestinal inflammation. Connolly KM, Hubert M, Miceli R, Okoye Z, Santiago G, Windle K, Wong E GASTROENTEROLOGY 2000 1184 Suppl 2 Abs 2987
11. 367248 Repifermin (Keratinocytes growth factor-2) stimulates Mucosal Hyperplasia following systemic treatment in cynomolgus monkeys. Parry TJ, Caputo FA, Farman C, Komburst D, Fikes JD, Jimennez P PROC AM SOC CLIN ONCOL 2000 19 May 20-23 Abs 2373
12. 368009 Favorable phase II results of repifermin in treatment of chronic venous ulcers reported by Human Genome Sciences. Human Genome Sciences Inc PRESS RELEASE 2000 May 23
13. 368013 Human Genome Sciences to initiate third phase II clinical trial program of repifermin; ulcerative colitis is newest indication. Human Genome Sciences Inc PRESS RELEASE 2000 May 23
14. 382215 First genomics-based drug shows clinical activity in human trials: Human Genome Sciences to move forward with a large efficacy and safety trial of repifermin. Human Genome Sciences Inc PRESS RELEASE 2000 September 13
15. 385959 Human Genome Sciences and Smithkline Beecham agree to jointly develop and commercialize Repifermin, an HGS product; Repifermin is in multiple clinical trials conducted by HGS for wound care, mucositis and inflammatory bowel disease. Human Genome Sciences Inc PRESS RELEASE 2000 October 16
16. 388821 Human Genome Sciences reports third quarter financial results. Human Genome Sciences Inc PRESS RELEASE2000 November 07
17. 391985 Annual report 1999 - Human Genome Sciences: The Healing Power of Knowledge. Human Genome Sciences Inc ANNUAL REPORT 2000 December 04
18. 396786 Financial presentations: the GSK story. GlaxoSmithKline pic COMPANY WORLD WIDE WEB SITE2000 November 21-22
19. 398329 Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulcération in rats. Dong SH, Li F, Holt L, Connolly K, Hubert M, Miceli R, Okoye Z, Santiago G, Windle K, Wong E, Balfour SR AM J PHYSIOL - GASTROINTEST LIVER PHYSIOL 2000 279 5 G1011 - G1022
20. 398495 Efficacy of growth factors in the accelerated closure of interstices in explanted meshed human skin grafts. Smith PD, Polo M, Soler PM, McClintock JS, Maggi SP, Kirn YJ, Ko F, Robson CM J BURN CAREREHABIL 2000 21 1 Pt 1 5 - 9
21. 398501 Keratinocyte growth factor promotes the survival, growth, and differentiation of preantral ovarian follicles. UcGee EA, Chun SY, Lai S, He Y, Hsueh AJ FERTIL STERIL 1999 71 4 732 - 738
22. 398502 Efficacy of keratinocyte growth factor-2 in dextran sulfate sodiuminduced murine colitis. Miceli R, Hubert M, Santiago G, Yao DL, Colennan TA, Huddleston KA, Conndly K J PHARMACOL EXP THER1999 290 1 464 - 471
23. 398503 Effects of keratinocyte growth factor-2 (KGF-2) on wound healing in an ischaemia-impaired rabbit ear model and on scar formation. Xia YP, Zhao Y, Marcus J, Jimenez PA, Ruben SM, Moore PA, Khan F, Mustoe TA J PATHOL 1999 188 4 431 - 438
24. 398504 Keratinocyte growth factor-2 accelerates wound healing in incisional wounds. Jimenez PA, Rampy MA J SURG RES 1999 81 2 238 - 242
25. 398505 Keratinocyte growth factor induced epithelial proliferation facilitates retroviral-mediated gene transfer to distal lung epithelia In vivo. Wang G, Slepushkin VA, Bodner M, Zabner J, Es HH, Thomas P, Jolly DJ, Davidson BL, McCray PB J GENE MED 1999 1 1 22 - 30
26. 399183 Human Genome Sciences reports financial results for fourth quarter and full year 2000. Human Genome Sciences Inc PRESS RELEASE 2001 February 15
27. 404294 Human Genome Sciences initiates phase lib clinical trial of Repifermin for venous ulcers. Human Genome Sciences Inc PRESS RELEASE2QQ1 April 05
28. 410730 GF regulates pulmonary epithelial proliferation and surfactant protein gene expression in adult rat lung. Yano T, Mason RJ, Pan T, Deterding RR, Nielsen LD, Shannon JM AM J PHYS LUNG CELL MOL PHYSIOL 2000 279 6 23 - 26
29. 410732 Keratinocyte growth factor and embryonic rat lung morphogenesis. Shiratori M, Oshika E, Ung LP, Singh G, Shinozuka H, Warburton D, Michalopoulos G, Katyal SL AM J RESPIR CELL MOL BIOL 1996153328-338
30. 412015 Genome Sciences. Warburg UBS ANALYST REPORT 2001 May 21